BusinessToday Previous Editions

4 NEWS 10.3.2022 ARRINGO Ltd, a market leader in busi- ness solutions and customer services acquired QGen, a fintech/risk manage- ment services company. is partner- ship aligns with Arringo's recent hiring of their new CEO Simon Camilleri, a veteran risk manager who said: ''We feel the QGen acquisition is a great compliment to Arringo's current portfolio and will enable the company to provide the level of services Arrin- go's clients have come to expect, while expanding services to a broader audi- ence. With the joint capabilities of both companies, this acquisition will enable Arringo to fulfil its future potential, and improve its seamless and high-quality services, covering all possible aspects from onboarding to KYC, marketing, payments and software and develop- ment.'' Arringo currently offers their clients a vast range of services, executed to the highest possible standard. ese in- clude back and front-end engineering, business development, full marketing and branding services as well as cus- tomer operations. Bringing QGen on- board, will help improve the seamless business solutions experiences cover- ing all aspects of the industry. Damian Mifsud, QGen Chief Executive Officer added: ''Qgen is very excited for the oppor- tunity to join forces with Arringo to build the next generation of compliance products with new initiatives, backed up with further investment. Since our early beginnings we have constantly in- novated and evolved to offer a distinc- tive combination of a technology plat- form with 3rd party orchestration and a multi jurisdiction team of highly skilled compliance professionals. As a unique provider of managed services catering to many of Europe's leading FinTech's and other regulated businesses we look forward to continuing pioneering com- pliance products that will truly help our clients and the industry'' Both companies are focused and driv- en by common aspirations and goals and look forward to the new opportu- nities for local and international com- panies that will be created through this strategic partnership. QGen is an inte- gral operator that prides itself on the credibility, security and safety they offer their clients through their exclusive and pioneering global KYC protocols. Damian Mifsud, Qgen CEO (left) and Simon Camilleri, Arringo CEO (right) Arringo Ltd. acquires QGen in strategic expansion move to become industry leader Fertility tech company opens RDI centre in Malta PERA Labs, a ground-breaking fertility tech company, has opened a RDI centre in Malta. e company uses artificial intelli- gence and lab-on-a-chip technology to help aspirational parents by assisting fertility clinics reduce their standard 70% treatment failure rate. e company has announced the start of research and development of an AI-powered sperm and egg selection technology for fertility treatments. e research and development places Malta at the centre of what is an interna- tional collaboration, with a Malta-based team of experts in reproductive health, deep-learning and microfluidics, team- ing up with Pera Labs's commerciali- zation advisors at the University City Science Center in Philadelphia and Wainamics - Pera Labs's award winning manufacturing partner in California, US and Austria. Pera Labs's Malta operations are ac- celerated by the €800,000 of financial support from Malta Enterprise, coupled with Pera Labs's own financing. Founder and CEO, Burak Özkösem, a longtime Ph.D. researcher of reproduc- tive health said that the company chose Malta as its European headquarters not only because it's sunny most of the year but also for its genuine hospitality towards cutting edge tech companies from US, Canada, Israel and beyond. "is financial and logistic support demonstrates strong innovative vision as a country. Our Malta base will be our headquarters for EU related CE Mark and GDPR compliance and regulatory affairs," Özkösem said. He said that, with English being the of- ficial language, Malta had created an in- ternational startup-friendly sandbox for companies' growth and soft landing in Europe. e Malta Enterprise team had been very welcoming and friendly from the application to due diligence and through the selection processes to the project implementation phase, he said. "Our global expansion began with a major step, which was choosing Mal- ta as our R&D facilities for developing AI-powered fertility treatment solu- tions to European couples and more. We are building the world's first and only fully automated device that not only analyzes sperm quality but also selects the best sperm cells for fertility treatments," Özkösem said. "is patent pending technology called SPERMAN® unlike other sys- tems, doesn't harm sperm or egg cells during the analysis and separation pro- cesses. Moreover, our technology is safe and tackles the fertility issues in men and women pre-conception stage there- fore not harming embryos at all." on news of the announcement, Kurt Farrugia, Malta Enterprise's CEO said Pera Lab's pioneering technology for reproductive health has the potential to dramatically increase the success of fer- tility treatments and drive down their costs. "We are looking forward for this highly-innovative company to join our growing local med-tech ecosystem and its developments to change lives in fer- tility clinics around the world," he said. "Our global expansion began with a major step, which was choosing Malta as our R&D facilities for developing AI-powered fertility treatment solutions to European couples and more"

• Cover